⌘K

Home/Filings/4/0001209191-12-040805

4//SEC Filing

Clendeninn Neil James 4

Accession 0001209191-12-040805

CIK 0000949858other

View on SEC.gov Company Profile

Filed

Aug 6, 8:00 PM ET

Accepted

Aug 7, 6:27 PM ET

Size

6.8 KB

Accession

0001209191-12-040805

Insider Transaction Report

Form 4

Period: 2012-08-03

ONCOGENEX PHARMACEUTICALS, INC.OGXI

Clendeninn Neil James

Director

Transactions

Exercise/Conversion
Common Stock
2012-08-03$4.11/sh+3,702$15,197→ 7,049 total
Exercise/Conversion
Stock Option
2012-08-03−3,702→ 0 total
Exercise: $4.11From: 2005-08-08Exp: 2012-08-08→ Common Stock (3,702 underlying)

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ONCOGENEX PHARMACEUTICALS, INC.

CIK 0000949858

Entity typeother

Related Parties

1

filerCIK 0001442443

Filing Metadata

Form type: 4
Filed: Aug 6, 8:00 PM ET
Accepted: Aug 7, 6:27 PM ET
Size: 6.8 KB

View on SEC.gov